Herriot Tabuteau, the Chief Executive Officer of Axsome Therapeutics, Inc. (NASDAQ: AXSM), has sold 49,252 shares of the company’s stock in a transaction on December 2,...
Healthcare Services Group (NASDAQ:HCSG) received a downgrade from a “strong-buy” to a “buy” rating by analysts at Wall Street Zen, according to a note released to...
On November 24, 2023, Bioventures 2014 L.P. Mpm, a significant shareholder of Werewolf Therapeutics, Inc. (NASDAQ: HOWL), sold 88,802 shares of the company. The shares were...
Wall Street experienced a significant rally on October 5, 2023, driven by a strong profit report from Nvidia and mixed signals from the U.S. job market....
Aclarion, Inc. (NASDAQ: ACON), a healthcare technology company, is currently assessing its standing among competitors in the Medical Services industry. This analysis evaluates Aclarion’s performance in...
Aclarion, Inc. (NASDAQ: ACON) has emerged as a notable player in the “Medical Services” sector, which comprises 93 publicly traded companies. A recent financial survey provides...
In a detailed analysis of two prominent companies in the medical sector, Standard BioTools (NASDAQ:LAB) and Veeva Systems (NYSE:VEEV), various factors such as valuation, institutional ownership,...
Investors are weighing options between two small-cap medical companies, FibroBiologics (NASDAQ:FBLG) and Phathom Pharmaceuticals (NASDAQ:PHAT). This analysis evaluates their earnings, profitability, valuation, analyst recommendations, risk factors,...
Equities researchers at Benchmark have initiated coverage of shares for Vital Farms (NASDAQ: VITL) with a “buy” rating and a price target of $60.00. This target...
Investment analysts have recently evaluated two medical companies, IceCure Medical and Tauriga Sciences, to determine which stock presents a stronger investment opportunity. This comparison assesses their...
